Patricia Shannon, Kartika Antonia, Puspitasari Irma Melyani
Bachelor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, West Java, Indonesia.
National Eye Center Cicendo Eye Hospital, Bandung 40117, West Java, Indonesia.
Medicina (Kaunas). 2025 Mar 28;61(4):626. doi: 10.3390/medicina61040626.
: The effects of COVID-19 disease can manifest and cause eye complications, one of which is diplopia. Diplopia is a medical condition that makes one object appear like two images. People may also experience diplopia after receiving the COVID-19 vaccine, after contracting COVID-19, or following a COVID-19 infection. : This review aims to summarize the cases of COVID-19 that can cause diplopia and its treatment in the past 5 years. The literature search databases used for this review were PubMed and Scopus. The keywords used were "diplopia," "COVID-19," and "treatment." Sixteen articles were reviewed after screening and applying the inclusion criteria. : The results show that over the past 5 years, cases of diplopia related to COVID-19 have occurred in America, Europe, Asia, and Africa. Most studies are case reports, and the total number of patients was 26, with an age range of 14 to 81. : The diplopia cases recovered within 1 day to 8 months. Patients who experienced diplopia after receiving the COVID-19 vaccine, during COVID-19 infection, or after COVID-19 infection exhibited different symptoms. Nasopharyngeal swabs, magnetic resonance imaging (MRI), computerized tomography (CT) scans, visual acuity tests, slit lamp biomicroscope examinations, eye movement tests, funduscopic examinations, and blood tests were the most commonly performed tests. Corticosteroids such as prednisone, methylprednisolone, and prednisolone were the most commonly used drugs to treat diplopia. In addition to corticosteroids, antibiotics, antivirals, antiplatelets, and vitamins were also given. An eye patch was considered to alleviate the diplopia.
新冠病毒疾病的影响可能会显现并引发眼部并发症，其中之一就是复视。复视是一种病症，会使一个物体看起来像两个影像。人们在接种新冠疫苗后、感染新冠病毒期间或感染新冠病毒之后也可能会出现复视。
本综述旨在总结过去5年中可导致复视的新冠病例及其治疗方法。本综述使用的文献检索数据库为PubMed和Scopus。使用的关键词为“复视”“新冠病毒”和“治疗”。经过筛选并应用纳入标准后，共审查了16篇文章。
结果显示，在过去5年中，与新冠病毒相关的复视病例在美洲、欧洲、亚洲和非洲均有发生。大多数研究为病例报告，患者总数为26例，年龄范围在14岁至81岁之间。
复视病例在1天至8个月内康复。在接种新冠疫苗后、感染新冠病毒期间或感染新冠病毒之后出现复视的患者表现出不同症状。鼻咽拭子、磁共振成像（MRI）、计算机断层扫描（CT）、视力测试、裂隙灯显微镜检查、眼球运动测试、眼底检查和血液检查是最常进行的检查。泼尼松、甲泼尼龙和泼尼松龙等皮质类固醇是治疗复视最常用的药物。除皮质类固醇外，还使用了抗生素、抗病毒药物、抗血小板药物和维生素。眼罩被认为可缓解复视。
